Formulation, Development and Evaluation of Bilayer Floating Tablet of Gemfibrozil
Abstract
Formulation development is an important part of drug design and development. Bioavailability and bioequivalence are totally dependent on formulation development. Now-a-days formulation development is done by following QbD (Quality by Design).The aim of present study is to formulate Gemfibrozil (Gem) sustained release (SR) and immediate release (IR) bilayer tablet by different concentration of Hydroxypropyl methylcellulose (HPMC) and HPMC K 100 M to control the release pattern. The sustained release layer of Gem was prepared by using different grades of HPMC like, HPMC K-15, HPMC K-4 along with other excipients by direct compression technique. The immediate release layer of Gem was prepared by Cross carmellose sodium, Crospovidone and Sodium starch glycolate by direct compression technique. The powders were evaluated for their flow properties and the finished tablets were evaluated for their physical parameters. The both immediate release and sustained release layers of Gem were characterized by FT-IR and in vitro dissolution studies. The drug release study of Gem was evaluated using USP-II paddle type dissolution apparatus. The release rate of Gem in immediate release layer was studied for 15 min in 0.1 N HCL media and that of Gem in sustained release layer was studied for 12 h in 0.1 N HCL. From the nine batches F6 batch showed good release behaviour 99.85% of drug is released over 12 hours. Gem belongs to BCS Class II (log P 3.6) with poor solubility and high permeability resulting in limited and variable bioavailability. Total four trial batches of each drug have been manufactured to optimize and develop a robust and stable formulation, the stability studies of the products also comply with ICH guideline.
Keywords: Bilayer floating tablets, Gemfibrozil, Biphasic drug release, HPMC K 15.
DOI
https://doi.org/10.22270/jddt.v9i4-s.3401References
Shaikh TK, Gadhave MV, Jadhav SL, Gaikwad DD. Different techniques of bilayer tablet: a review. Int J Univ Pharm Life Sci 2012; 2(2): 450-460.
Mayavanshi AV, Gajjar SS. Floating drug delivery systems to increase gastric retention of drugs: A review. J Pharm Tech 2008; 1(14): 345-348.
Patra CN, Kumar AB, Pandit HK, Singh SP, Devi MV. Design and evaluation of sustained release bilayer tablets of propranolol hydrochloride, Acta Pharm 2007; 57: 479-489.
Deshpande RD, Gowda DV, Mahammed M, Maramwar DN, Bi-Layer tablets-an emerging trend: a review, Int J Pharm Sci Res2011; 2(10); 2534-2544.
Yadav BV, Yadav VA. Enhancement of solubility and dissolution rate of BCS class II pharmaceuticals by nonaquious granulation technique. Int J Pharma Res Devel 2010; 1: 1‐12.
Taneja S, Shilpi S, Khatri K. Formulation and optimization of efavirenz nanosuspensions using the precipitation-ultrasonication technique for solubility enhancement. Artif Cells Nanomed Biotechnol 2016; 44:978 84.
Patel R, Baviskar T, Rajput A. Development and in-vivo characterization of SMEDDs (self-microemulsifying drug delivery system) for gemfibrozil. Int J Pharm Pharm Sci 2013; 5:793-800.
Talib H, Watersa L, Gareth M, Parkes G. Microwave processed solid dispersions for enhanced dissolution ofgemfibrozil using non-ordered mesoporous silica. Colloids Surf A Physicochem Eng Asp 2017;520:428-35
Huang QP, Wang JX, Chen GZ, Shen ZG, Chen JF, Yun J. Micronization of gemfibrozil by reactive precipitation process. Int J Pharm 2008; 360:58-64.
Liberman HA, Lachman L, Schwartz JB. Pharmaceutical dosage forms: Tablets, 3rd edition, Marcel Dekker, New York, 1990.
Lordi GN. Sustained release dosage forms. In: Lachman L, Liberman HA, Kanig JL, 3rd edition. The Theory and Practice of Industrial Pharmacy. Mumbai, India: Varghese Publishing House; 1987:430-456;
Aulton ME; Wells TI; Pharmaceutics: The Science of Dosage Form Design, Churchill Livingstone, London, England, 1988.
Published
Abstract Display: 843 
PDF Downloads: 665 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.